2nd Model-Informed Drug Development Summit

Certara is an Expertise Partner of the summit.

Certara is proud to support the 2nd Model-Informed Drug Development Summit, where clinical pharmacology, pharmacometrics, QSP, and regulatory leaders gather around the questions now shaping MIDD in practice: turning model-informed evidence into decisions regulators accept, preparing for ICH M15, and scaling quantitative methods beyond a single program. As the FDA MIDD Pilot Program, Project Optimus, and ICH M15 raise the bar on what sponsors are expected to bring, Certara’s modeling, simulation, and regulatory expertise offers a practical route through the dosing, evidence, and submission questions teams are working through right now.